Sign in to view content

Cost of Initial Aflibercept, Laser, or Observation in Eyes With Diabetic Macular Edema and Good Vision Based on Management Approaches in Protocol V

Jennifer K. Sun, MD

Video
Published 2020

Related

Risk of Diabetic Retinopathy Progression in Patients During 1 year of Semaglutide Use
Blake A. Cooper, MD MPH
Updates from the Field
2022
A Model to Predict the 3-Year Risk of Needing Treatment for Diabetic Macular Edema
Bobeck S Modjtahedi, MD
Annual Meeting Talks
2018
Longitudinal Panretinal Leakage Index Assesment in Proliferative Diabetic Retinopathy Treated With Aflibercept From the RECOVERY Study
Amy S. Babiuch, MD, FASRS
Annual Meeting Talks
2019

Category: Socioeconomics

See more